Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Am Chem Soc ; 133(23): 8810-3, 2011 Jun 15.
Article in English | MEDLINE | ID: mdl-21473587

ABSTRACT

The discovery of molecules that bind tightly and selectively to desired proteins continues to drive innovation at the interface of chemistry and biology. This paper describes the binding of human insulin by the synthetic receptor cucurbit[7]uril (Q7) in vitro. Isothermal titration calorimetry and fluorescence spectroscopy experiments show that Q7 binds to insulin with an equilibrium association constant of 1.5 × 10(6) M(-1) and with 50-100-fold selectivity versus proteins that are much larger but lack an N-terminal aromatic residue, and with >1000-fold selectivity versus an insulin variant lacking the N-terminal phenylalanine (Phe) residue. The crystal structure of the Q7·insulin complex shows that binding occurs at the N-terminal Phe residue and that the N-terminus unfolds to enable binding. These findings suggest that site-selective recognition is based on the properties inherent to a protein terminus, including the unique chemical epitope presented by the terminal residue and the greater freedom of the terminus to unfold, like the end of a ball of string, to accommodate binding. Insulin recognition was predicted accurately from studies on short peptides and exemplifies an approach to protein recognition by targeting the terminus.


Subject(s)
Bridged-Ring Compounds/metabolism , Imidazoles/metabolism , Insulin/metabolism , Binding Sites , Humans , Insulin/chemistry , Models, Molecular , Phenylalanine/metabolism , Protein Binding , Protein Conformation , Substrate Specificity
2.
Mol Cell Biol ; 33(3): 622-34, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23184663

ABSTRACT

RhoA is overexpressed in human cancer and contributes to aberrant cell motility and metastatic progression; however, regulatory mechanisms controlling RhoA activity in cancer are poorly understood. Neuroepithelial transforming gene 1 (Net1) is a RhoA guanine nucleotide exchange factor that is overexpressed in human cancer. It encodes two isoforms, Net1 and Net1A, which cycle between the nucleus and plasma membrane. Net1 proteins must leave the nucleus to activate RhoA, but mechanisms controlling the extranuclear localization of Net1 isoforms have not been described. Here, we show that Rac1 activation causes relocalization of Net1 isoforms outside the nucleus and stimulates Net1A catalytic activity. These effects do not require Net1A catalytic activity, its pleckstrin homology domain, or its regulatory C terminus. We also show that Rac1 activation protects Net1A from proteasome-mediated degradation. Replating cells on collagen stimulates endogenous Rac1 to relocalize Net1A, and inhibition of proteasome activity extends the duration and magnitude of Net1A relocalization. Importantly, we demonstrate that Net1A, but not Net1, is required for cell spreading on collagen, myosin light chain phosphorylation, and focal adhesion maturation. These data identify the first physiological mechanism controlling the extranuclear localization of Net1 isoforms. They also demonstrate a previously unrecognized role for Net1A in regulating cell adhesion.


Subject(s)
Cell Movement , Focal Adhesions/metabolism , Oncogene Proteins/metabolism , rac1 GTP-Binding Protein/metabolism , Animals , Blood Proteins/chemistry , Blood Proteins/metabolism , Breast Neoplasms/metabolism , Cell Line, Tumor , Cell Membrane/metabolism , Female , Gene Expression , Humans , Mice , Myosin Light Chains/metabolism , Oncogene Proteins/analysis , Phosphoproteins/chemistry , Phosphoproteins/metabolism , Phosphorylation , Proteasome Endopeptidase Complex/metabolism , Protein Isoforms/analysis , Protein Isoforms/metabolism , Protein Structure, Tertiary , cdc42 GTP-Binding Protein/metabolism , p21-Activated Kinases/metabolism , rac1 GTP-Binding Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL